Drug Shortage Report for VARIVAX III
| Report ID | 221683 |
| Drug Identification Number | 02246081 |
| Brand name | VARIVAX III |
| Common or Proper name | varicella virus vaccine, live, attenuated [Oka/Merck]) Lyophilized powder for injection |
| Company Name | MERCK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | |
| Strength(s) | 1350UNIT |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 1 DOSE VIAL |
| ATC code | J07BK |
| ATC description | VIRAL VACCINES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2024-03-07 |
| Estimated end date | 2024-03-29 |
| Actual end date | 2024-03-22 |
| Shortage status | Resolved |
| Updated date | 2024-03-23 |
| Company comments | Remaining doses are reserved for the public immunization program. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2024-03-23 | French | Compare |
| v6 | 2024-03-22 | French | Compare |
| v5 | 2024-03-22 | English | Compare |
| v4 | 2024-03-08 | French | Compare |
| v3 | 2024-03-08 | English | Compare |
| v2 | 2024-03-08 | French | Compare |
| v1 | 2024-03-08 | English | Compare |
Showing 1 to 7 of 7